Banner Image

Test Directory

TSH Antibody

Test Summary

This test may help identify thyroid stimulating hormone (TSH) autoantibodies. When the serum TSH level is discordant with clinical manifestations or other test results (eg, markedly elevated TSH with normal free triiodothyronine and free thyroxine levels), this test may be used to determine if TSH autoantibodies are the cause of discordance.

TSH autoantibodies can bind TSH to form a macromolecule (macro-TSH) that has low biological activity but interferes with TSH immunoassays [1]. Interference by macro-TSH may be screened by polyethylene glycol precipitation and gel filtration chromatography [1].

Anomalous TSH levels may also be caused by a range of interfering substances, such as biotin, heterophilic antibodies, and antibodies to streptavidin and ruthenium [1].

Other conditions that may result in elevated TSH levels with normal free triiodothyronine and free thyroxine levels include subclinical hypothyroidism, poor adherence to (or malabsorption of) thyroxine therapy, certain drugs (eg, amiodarone), nonthyroidal illness recovery phase, and TSH resistance [2].

The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.

References
1. Favresse J, et al. Endocr Rev. 2018;39(5):830-850.
2. Gurnell M, et al. Clin Endocrinol (Oxf). 2011;74(6):673-678.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1 mL serum

Minimum Volume

0.5 mL

Instructions

N/A

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 14 days
  • Refrigerated: 14 days
  • Frozen: 28 days

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

Plasma

Order Code

TSHAB

EPIC (Premier) Code

LAB5006

Includes

N/A

CPT Code

  • 83519

Billing Code

  • 700000

CPT Statement

Methodology

Radioimmunoassay (RIA)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Reference Range

Negative

Setup Schedule / Expected Turnaround Time

Sunday, Wedensday; Report available: 4 - 8 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1 mL serum

Minimum Volume

0.5 mL

Instructions

N/A

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 14 days
  • Refrigerated: 14 days
  • Frozen: 28 days

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

Plasma

Billing

CPT Code

  • 83519

Billing Code

  • 700000

CPT Statement

Result Information

Methodology

Radioimmunoassay (RIA)

Testing Laboratory

N/A

Reference Range

Negative

Setup Schedule / Expected Turnaround Time

Sunday, Wedensday; Report available: 4 - 8 days